Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines

BACKGROUND: SARS-CoV-2 Omicron variant evades immunity from past infection or vaccination and is associated with a greater risk of reinfection among recovered COVID-19 patients. We assessed the serum neutralizing antibody (NAb) activity against Omicron variant (Omicron NAb) among recovered COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Lu, Chen, Lin-Lei, Zhang, Ricky Rui-Qi, Tsang, Owen Tak-Yin, Chan, Jacky Man-Chun, Tam, Anthony Raymond, Leung, Wai-Shing, Chik, Thomas Shiu-Hong, Lau, Daphne Pui-Ling, Choi, Chris Yau-Chung, Fong, Carol Ho-Yan, Cai, Jian-Piao, Tsoi, Hoi-Wah, Choi, Charlotte Yee-Ki, Zhang, Xiaojuan, Abdullah, Syed Muhammad Umer, Chan, Brian Pui-Chun, Chan, Kwok-Hung, Yuen, Kwok-Yung, Hung, Ivan Fan-Ngai, To, Kelvin Kai-Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989491/
https://www.ncbi.nlm.nih.gov/pubmed/35398786
http://dx.doi.org/10.1016/j.ebiom.2022.103986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989491/
https://www.ncbi.nlm.nih.gov/pubmed/35398786
http://dx.doi.org/10.1016/j.ebiom.2022.103986

Ejemplares similares